Mustang bio, inc. (MBIO)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Sep'15
Revenue - related party

-

-

0

0

-

-

0

0

-

-

0

0

0

-

-

-

-

-

Operating expenses:
Research and development

32,396

30,042

29,031

27,038

23,772

21,104

15,720

12,592

11,529

7,943

6,138

4,519

2,607

2,468

2,288

0

0

0

Research and development - licenses acquired

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

Research and development - licenses acquired

-

-

-

3,935

-

-

-

10,433

11,933

12,433

8,454

8,154

6,654

6,079

0

0

0

0

General and administrative

9,182

9,570

9,196

8,549

7,043

6,759

8,200

11,456

11,444

11,409

9,294

5,799

4,586

2,816

1,902

0

0

0

Total operating expenses

47,651

45,885

41,862

39,522

34,550

31,223

35,053

34,481

34,906

31,785

0

0

0

-

0

0

-

0

Loss from operations

-47,651

-45,885

-41,862

-39,522

-34,550

-31,223

-35,053

-34,481

-34,906

-31,785

-23,886

-18,472

-13,847

-11,363

-4,190

0

0

0

Other income (expense)
Interest income

1,374

1,263

1,083

815

575

569

568

574

561

505

384

240

106

16

0

0

0

-

Interest income - related party

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

Interest expense - related party

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

-

-

Interest expense - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Interest expense

2,356

1,767

1,171

593

19

8

0

0

0

-

-

-

-

-

0

-

-

0

Change in fair value of derivative liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

Total other income (expense)

-982

-504

-88

222

556

561

0

0

0

-

-

-893

-1,122

-1,291

-432

0

0

0

Net Loss

-48,633

-46,389

-41,950

-39,300

-33,994

-30,662

-34,493

-33,915

-34,351

-31,288

-24,435

-19,365

-14,969

-12,654

-4,622

0

0

0

Net loss per common share outstanding, basic and diluted

-0.28

-0.41

-0.25

-0.29

-0.34

-0.43

-0.28

-0.19

-0.24

-0.62

-0.27

-0.21

-0.14

-0.76

-0.19

-0.11

-0.09

-0.07

Weighted average number of common shares outstanding, basic and diluted

41,971

40,119

39,875

36,306

27,945

27,175

27,146

27,087

26,387

26,243

26,186

26,180

22,401

13,715

10,089

10,250

10,052

10,000